Medicines regulator receives 46 reports of hospitalisations linked to weight-loss drugs
As of 16 August 2024, the MHRA had received 5,073 reports of common gastrointestinal reactions related to GLP-1 RA use, of which 46 reported hospitalisation of the individual.…
Published: 25 October 2024